ELI
Learn

Ritivel - Artificial Intelligence and Machine Learning Tool

Artificial Intelligence and Machine Learning · Founded by Pavan Kalyan in 2024

Ritivel

Ritivel

AI-native platform for Life-Sciences Documentation

Cost

Demo

Rating

People love it

Time to value

Moderate Setup (1-3 hours)

You can use Ritivel to draft regulatory documents like Clinical Study Reports, IND submissions, and CTD modules for pharmaceutical companies. The AI system provides word-level traceability, meaning every statement can be traced back to its source document. You can generate complete CSRs from protocols and statistical analysis plans, automate literature searches, and create Module 2 summaries with cross-references. The system deploys locally on your infrastructure to maintain data security and compliance. It's specifically trained on medical and regulatory language to reduce errors in high-stakes submissions.

What Ritivel does

Convert protocols and SAPs into complete CSRsTrace every document statement to source materialsSearch regulatory guidelines for specific requirementsGenerate literature summaries from PubMed searchesCreate cross-referenced CTD module sectionsDraft nonclinical study reports with AI assistanceAutomate table and figure generation from dataMaintain consistent narrative across document versionsWord-level traceability for every statement100% local deployment with no cloud storageDomain-specific training on medical terminologyGenerates complete CSRs from protocol inputsAuto-generates tables, listings, and figuresLiterature search integration with PubMedCross-reference automation for CTD modulesAir-gapped deployment capability

Frequently asked

Want a tailored answer?

See whether Ritivel fits your stack.

Techbible weighs Ritivel against what you already pay for, your team shape, and the work that's actually happening. Free to start.

Ritivel, clinical study reports, regulatory submissions, pharmaceutical AI, CTD automation, FDA submissions, biotech documents, medical writing, regulatory affairs, clinical research, life sciences, IND applications, drug development, regulatory compliance, medical device submissions